Published in Lancet on August 11, 2012
Activation of afferent renal nerves modulates RVLM-projecting PVN neurons. Am J Physiol Heart Circ Physiol (2015) 1.48
Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension (2014) 1.18
Systolic hypertension: an increasing clinical challenge in Asia. Hypertens Res (2014) 0.88
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens (2015) 0.88
Assessment and management of resistant hypertension. CMAJ (2014) 0.86
Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA). Aging Dis (2014) 0.81
Facilitated hyperpolarization signaling in vascular smooth muscle-overexpressing TRIC-A channels. J Biol Chem (2013) 0.81
Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. Curr Hypertens Rep (2013) 0.78
The autonomic nervous system and renal physiology. Int J Nephrol Renovasc Dis (2013) 0.77
Participation of 5-HT and AT1 Receptors within the Rostral Ventrolateral Medulla in the Maintenance of Hypertension in the Goldblatt 1 Kidney-1 Clip Model. Int J Hypertens (2014) 0.77
Effects of aqueous leaf extract of Asystasia gangetica on the blood pressure and heart rate in male spontaneously hypertensive Wistar rats. BMC Complement Altern Med (2013) 0.77
The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC Trial): study protocol for a randomized controlled trial. Trials (2015) 0.76
Alkaloids in Erythrina by UPLC-ESI-MS and In Vivo Hypotensive Potential of Extractive Preparations. Evid Based Complement Alternat Med (2015) 0.75
Novel strategies for treatment of resistant hypertension. Kidney Int Suppl (2011) (2013) 0.75
Consensus of Chinese Specialists on Diagnosis and Treatment of Resistant Hypertension. Chin Med J (Engl) (2015) 0.75
Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy. ACS Med Chem Lett (2013) 0.75
Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow. Auton Neurosci (2016) 0.75
The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC-Trial): a randomized controlled first-in-human trial. Br J Clin Pharmacol (2017) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol (1985) (2010) 9.76
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation (2011) 2.88
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol (2009) 2.04
Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension (2010) 2.01
Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension (2007) 1.90
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J (2012) 1.74
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension (2012) 1.54
Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens (2002) 1.53
Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension (2006) 1.51
Interactions between leptin and the human sympathetic nervous system. Hypertension (2003) 1.44
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics (2003) 1.32
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol (2011) 1.22
Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol (2008) 1.21
Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation (2011) 1.18
Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med (2002) 1.15
Increased suicide rate in the middle-aged and its association with hours of sunlight. Am J Psychiatry (2003) 1.14
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens (2007) 1.12
Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol (2011) 1.12
Blood pressure and sympathetic nervous system response to renal denervation. Hypertension (2012) 1.08
Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol (2008) 1.02
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol (1985) (2006) 1.01
Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens (2012) 1.00
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol (2005) 0.97
Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One (2013) 0.96
Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res (2005) 0.94
The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol (2006) 0.94
The neurobiology of human obesity. Exp Physiol (2005) 0.94
Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens (2010) 0.94
Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension (2011) 0.93
Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol (2012) 0.92
Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol (2015) 0.89
Heart and mind: psychogenic cardiovascular disease. J Hypertens (2009) 0.88
Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci (2008) 0.87
Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol (2012) 0.86
European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens (2010) 0.86
Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol (2005) 0.86
Advances in sympathetic nerve recording in humans. Front Physiol (2012) 0.86
Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol (2008) 0.85
New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84
Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens (2012) 0.83
Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? Hypertension (2010) 0.82
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab (2004) 0.82
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention (2013) 0.82
Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. Hypertension (2010) 0.81
Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension (2013) 0.81
Sympathetic nervous system neuroplasticity. Hypertension (2006) 0.81
Novel procedure- and device-based strategies in the management of systemic hypertension. Eur Heart J (2011) 0.80
Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol (2010) 0.80
The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? J Hypertens (2002) 0.80
Autonomic responses to stress in Black versus Caucasian Africans: the SABPA study. Psychophysiology (2011) 0.80
Is very high sympathetic tone in heart failure a result of keeping bad company? Hypertension (2003) 0.79
Morning surge in blood pressure is associated with reactivity of the sympathetic nervous system. Am J Hypertens (2014) 0.79
Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul Pept (2002) 0.79
Home blood pressure monitoring: Australian Expert Consensus Statement. J Hypertens (2015) 0.79
Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol (2013) 0.78
How to measure home blood pressure: Recommendations for healthcare professionals and patients. Aust Fam Physician (2016) 0.78
Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer. Medicine (Baltimore) (2016) 0.78
Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. JACC Cardiovasc Interv (2013) 0.78
An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure. Clin Auton Res (2004) 0.77
Depression and blood pressure control: All antidepressants are not the same. Hypertension (2009) 0.77
Renal sympathetic nerve ablation for treatment-resistant hypertension. Br J Clin Pharmacol (2013) 0.77
NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro. Regul Pept (2004) 0.77
The Role of Central Nervous System Mechanisms in Resistant Hypertension. Curr Hypertens Rep (2015) 0.77
Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. Curr Hypertens Rep (2015) 0.77
Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry. J Hypertens (2016) 0.77
Regulation of the sympathetic nervous system by the kidney. Curr Opin Nephrol Hypertens (2014) 0.76
Is essential hypertension sometimes a psychosomatic disorder? J Hypertens (2004) 0.76
From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go? EuroIntervention (2014) 0.76
Response to more research is needed to investigate the effect of denervation on blood pressure. Hypertension (2014) 0.75
Reduced HRV and baroreflex sensitivity as universally applicable cardiovascular "risk factors"; waiting for the bubble to burst. Clin Auton Res (2003) 0.75
Depressive illness, the sympathetic nervous system and cardiac risk. J Hypertens (2009) 0.75
On a low calorie diet, are there separate and discrete effects of negative energy balance and weight loss on blood pressure? J Hypertens (2003) 0.75
Development of the metabolic syndrome along the female biological life-path. J Hypertens (2006) 0.75
Rebuttal from Esler, Lambert, and Schlaich. J Appl Physiol (1985) (2010) 0.75